Business
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
Saint-Herblain (France), October 27, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at upcoming investor conferences in the United States and Europe. Valneva will host moderated “fireside chat” presentations to discuss the Company’s key value drivers and upcoming catalysts, primarily the upcoming Phase 3 trial outcomes for VLA15, the Company
About this update from Valneva Se
[{"type":"image","alt":"VALNEVA","displaySize":"","headline":null,"caption":"VALNEVA","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":44,"url":"https://media.zenfs.com/en/globenewswire.com/29df7eb71c048b91fe66a95a1cd8b1d6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9l2h5dKc1PlSY26lXUAWsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTYyO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/29df7eb71c048b91fe66a95a1cd8b1d6","width":300,"height":44}},"lazy":false},{"type":"text","content":"Saint-Herblain (France), October 27, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at upcoming investor conferences in the United States and Europe.","length":306,"tagName":"p","attribs":{}},{"type":"text","content":"Valneva will host moderated “fireside chat” presentations to discuss the Company’s key value drivers and upcoming catalysts, primarily the upcoming Phase 3 trial outcomes for VLA15, the Company’s Lyme disease vaccine candidate, which is partnered with Pfizer. If successful, Pfizer aims to submit applications for U.S. and European market authorization in 2026. Pending approval, Valneva expects Pfizer to launch the vaccine in the second half of 2027.","length":452,"tagName":"p","attribs":{}},{"type":"text","content":"Guggenheim 2nd Annual Healthcare Innovation Conference Date/Time: November 10, 10:30am EST Format: Fireside chat and investor meetings Location: Boston, Massachusetts","length":184,"tagName":"p","attribs":{}},{"type":"text","content":"Stifel 2025 Healthcare Conference Date/Time: November 11, 9:20am EST Format: Fireside chat and investor meetings Location: New York, New York","length":159,"tagName":"p","attribs":{}},{"type":"text","content":"Jefferies London Healthcare Conference Date/Time: November 19, 2:00pm GMT Format: Fireside chat and investor meetings Location: London, United Kingdom Webcast Link: https://wsw.com/webcast/jeff332/vla/1693849","length":232,"tagName":"p","attribs":{}},{"type":"text","content":"A replay of the webcast will be available following the live events in the “Investor” section of the Valneva website at www.valneva.com.","length":136,"tagName":"p","attribs":{}},{"type":"text","con...